Other assets 2,057 406
Total assets $210,386 $101,725
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $21,887 $5,917
Accrued expenses 9,874 4,104
Due to affiliates 2,774 -
Current portion of long-term debt - 2,800
Total current liabilities 34,535 12,821
Deferred revenue 19,530 229
Long-term debt 25,000 4,617
Other long term obligations 1,604 649
Total liabilities 80,669 18,316
Commitments and contingencies - -
Stockholders' equity:
Common stock: par value $0.001,
100,000,000 shares authorized:
36,771,893 and 27,806,543 shares
issued and outstanding as of December 31,
2007 and December 31, 2006, respectively 37 28
Additional paid-in capital 311,172 206,848
Accumulated deficit (182,036) (123,640)
Accumulated other comprehensive income 544 173
Total stockholders' equity 129,717 83,409
Total liabilities and stockholders'
equity $210,386 $101,725
NxStage Medical, Inc.
Revenue by Market
Three Months Ended Twelve Months Ended
December 31,
'/>"/>
| SOURCE NxStage Medical, Inc. Copyright©2008 PR Newswire. All rights reserved |